Ter­ri­ble op­tics: As­traZeneca shares take a hit fol­low­ing re­port that CEO So­ri­ot is mov­ing to Te­va

You can in­sert this sto­ry in the WTF? file.

Wednes­day af­ter­noon Is­rael’s Cal­cal­ist re­port­ed that As­traZeneca CEO Pas­cal So­ri­ot has agreed to take the CEO’s job at Te­va, fill­ing a role left open at a com­pa­ny that is in the mid­dle of a ma­jor up­heaval.

The Is­raeli fi­nan­cial news web site says that So­ri­ot has per­son­al­ly signed off on the new job, ac­cept­ing a $20 mil­lion bonus, ac­cord­ing to a sto­ry from Reuters. And Haaretz fol­lowed up with its own con­fir­ma­tion that So­ri­ot has agreed to take the Te­va job, the sec­ond non-Is­raeli to take the po­si­tion, though they are still dis­cussing terms. The Haaretz re­port al­so in­clud­ed word of the $20 mil­lion bonus.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN